Angle PLC Announces Parsortix Based PD-L1 Assay Showcased at AACR 
CNS Pharmaceuticals Announces Virtual Investor KOL Connect Segment
Segment featuring leading Neuro-Oncologist and Glioblastoma Key Opinion Leader, Professor Michael WellerAccess the segment here HOUSTON, TX / ACCESSWIRE /...
Bronx NYC Medical Malpractice Law Firm ASK4SAM Expands Focus on Construction & Job Site Accidents, Slip & Fall Injury Cases
Garden City, New York--(Newsfile Corp. - November 4, 2024) - Silberstein, Awad & Miklos, P.C. (ASK4SAM), a prominent Bronx-based medical...
Safe Supply Streaming Co. Ltd. Announces Signing of Definitive Agreement to Acquire Drug Lab 118 Ltd
Toronto, Ontario--(Newsfile Corp. - November 4, 2024) - Safe Supply Streaming Co. Ltd. (CSE: SPLY) (FSE: QM4) (OTCQB: SSPLF) ("Safe...
Healing Realty Trust Appoints Richard Gatward to Advisory Board
Jupiter, Florida--(Newsfile Corp. - November 4, 2024) - Healing Realty Trust ("HRT" or the "Company"), a data-driven, self-managed real estate...
CBIH Welcomes Charles Tamburello to Its Board, Strengthening M&A Strategy
Houston, Texas--(Newsfile Corp. - November 4, 2024) - Cannabis Bioscience International Holdings (OTC Pink: CBIH) is thrilled to announce the...
Abstract Describing Significant Results of Crofelemer for Cancer Therapy-Related Diarrhea in Breast Cancer Patients Accepted for Presentation at San Antonio Breast Cancer Symposium (SABCS)
Adult patients with breast cancer are a prespecified subgroup of the recently conducted OnTarget trial evaluating crofelemer for prophylaxis of...
Catheter Precision, Inc. Announces New Clinical Data Presented at SCRN
FORT MILL, SC / ACCESSWIRE / November 4, 2024 / Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device...
CureVac Strengthens Leadership Team with Appointment of Seasoned Industry Executive Axel Sven Malkomes as Chief Financial Officer
Experienced CFO and investment banker with 30-year track record will help drive CureVac's transformationTÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE...
CureVac to Present at the 12th International mRNA Health Conference
TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / November 4, 2024 / CureVac N.V. (Nasdaq:CVAC) ("CureVac"), a global biopharmaceutical company...
NLS Pharmaceutics and Kadimastem Enter into a Definitive Merger Agreement
ZURICH, SWITZERLAND and NESS ZIONA, ISRAEL / ACCESSWIRE / November 4, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP) ("NLS"), a biopharmaceutical...
Philips enrolls first patient in U.S. clinical trial for innovative integrated single-device to treat peripheral artery disease
THOR Integrated Device With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device,...
Myriad Genetics Comments on UnitedHealthcare’s Updated Medical Policy for Pharmacogenetic Testing
SALT LAKE CITY, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and...
Renovaro Issues Shareholder Letter and Provides Corporate Update
LOS ANGELES, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB), a pioneer in cancer diagnostics and therapeutics powered...
Surrozen and TCGFB, Inc. Announce Strategic Research Collaboration to Develop TGF-β Antibodies for Idiopathic Pulmonary Fibrosis
Research collaboration to leverage Surrozen’s antibody research capabilities and expertise to discover a potential first in class treatment for patients...
IRADIMED CORPORATION Named to Fortune’s 100 Fastest Growing Companies List for 2024
WINTER SPRINGS, Fla., Nov. 04, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) was recently named one of...
Parity Healthcare Analytics joins Synova to support safe, financially sustainable nurse staffing
ROCKVILLE, Md., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Parity Healthcare Analytics has joined Synova Associates as a top-tier Premium Industry...
CytoDyn Announces FDA Clearance of Its Phase II Oncology Trial
VANCOUVER, Washington, Nov. 04, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing...
CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium
BERKELEY HEIGHTS, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and...
Vireo Growth Inc. Announces New $10 Million Convertible Debt Facility
MINNEAPOLIS, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Vireo Growth Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF), a cannabis...
Allogene Therapeutics Announces Participation in November Investor Conferences
SOUTH SAN FRANCISCO, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering...